Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer
Conditions: Bile Duct Cancer Interventions: Drug: Gemcitabin, Cisplatin and Durvalumab; Procedure: Biliary Radiofrequency Ablation; Procedure: Endoscopic Retrograde Cholangio-Pancreatography with stenting Sponsors: Insel Gruppe AG, University Hospital Bern; Swiss Cancer League Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bile | Bile Duct Cancer | Cancer | Cancer & Oncology | Cholangiocarcinoma | ERCP | Hospitals | Research | Switzerland Health